HOME >> MEDICINE >> NEWS
Japanese doctors likelier than US counterparts to involve patients' families in decisions

Medical residents in Japan are more likely to involve patients' families in end-of-life decision making--and to favor informing family members over the patients first-- than their United States counterparts, who prefer dealing directly with the patient, according to a new study conducted by Dr. Bob Gabbay and colleagues.

Yet the Japanese medical residents are more conflicted about their approach compared with medical residents in the U.S.

The findings reflect cultural norms in the two countries, said lead researcher Baback B. Gabbay who was a fourth-year medical student at UCLA at the time the study was written. Family ties are stronger in Japan than in the U.S., where a tradition of individualism is more culturally ingrained. However, the degree of uncertainty in the responses of Japanese (medical?) residents may reflect changing cultural norms in Japan.

"Traditionally, the family in Japan usually decides what to tell the patient," Gabbay said. "It's different than in the United States, where the individual autonomy to make decisions is perceived as relatively more important."

"Negotiating End-of-Life Decision Making: A Comparison of Japanese and U.S. Residents' Approaches" is published in the July issue of Academic Medicine.

The researchers distributed surveys to 244 Japanese and 103 U.S. medical residents. Response rates were 74 percent for the Japanese residents and 71 percent among U.S. residents.

Among the findings:

  • 95 percent of Japanese residents said they would inform both patient and family about a metastatic cancer diagnosis, with 99 percent of that group reporting they would notify the family first. By contrast, 53 percent of U.S. residents said they would speak only with the patient and just 2 percent said they would inform the family first.

  • 72 percent of the Japanese residents said that both patient and family should be told a metastatic cancer prognosis, with 23 perce
    '"/>


Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
25-Jun-2005


Page: 1 2 3

Related medicine news :

1. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
2. Japanese adults with diabetes have increased cancer risk
3. Consumption of green tea associated with reduced mortality in Japanese adults
4. Japanese encephalitis widespread in Bali
5. One dose of vaccine against Japanese encephalitis provides sustained protection
6. 6 out of 10 doctors arent frustrated that patients cant lower cholesterol
7. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
8. New doctors test kit to help prevent debilitating osteoporosis
9. Italian doctors get their information on medicines from drug company sales reps
10. Approved medical resident hours still resulting in sleepy doctors
11. MTAS will cause irreparable harm to 10,000 junior doctors

Post Your Comments:
(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: